Haemophilia: open trials in South Korea

10 open trials have a site in South Korea. Registry data; only the trial team decides who can take part.

NCT07416604
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
Trial Treatment · Phase 3 · Hoffmann-La Roche
Kyungpook National University Hospital, Daegu
Registry updated 2026-11-03
NCT05145127
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
Trial Treatment · Phase 3 · Pfizer
Kyungpook National University Hospital, Daegu · Severance Hospital, Yonsei University Health System, Seoul · Kyung Hee University Hospital at Gangdong, Seoul
Registry updated 2026-10-26
NCT07416526
A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
Trial Treatment · Phase 3 · Hoffmann-La Roche
Kyung Hee University Hospital at Gangdong, Gangdong-gu · Chonnam National University Hwasun Hospital, Hwasun-gun
Registry updated 2026-10-26
NCT05611801
A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
Trial Treatment · Phase 3 · Pfizer
Kyungpook National University Hospital, Daegu · Severance Hospital, Yonsei University Health System, Seoul · Kyung Hee University Hospital at Gangdong, Seoul
Registry updated 2026-10-14
NCT05568719
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
Trial Treatment · Phase 3 · Pfizer
Kyung Hee University Hospital at Gangdong, Seoul
Registry updated 2026-10-07
NCT06550882
A Study of OBIZUR in Adults With Acquired Hemophilia A (AHA) in South Korea
Research · Takeda
Ewha Womans University Medical Center, Seoul · The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul · Kyung Hee University Hospital at Gangdong, Seoul · Ulsan University Hospital, Ulsan
Registry updated 2026-09-11
NCT06003387
Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)
Trial Treatment · Phase 3 · CSL Behring
Kyungpook National University Hospital, Daegu · Severance Hospital, Yonsei University Health System, Seoul · Kyung Hee University Hospital at Gangdong, Seoul
Registry updated 2026-08-27
NCT06222697
A Study to Learn More About the Safety of Damoctocog-alfa-pegol When Used in Routine Medical Care in Korean Participants With Hemophilia A
Research · Bayer
Many Locations, Multiple Locations
Registry updated 2026-06-22
NCT05768386
A Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)
Research · Phase 4 · BioMarin Pharmaceutical
Kyung Hee University Hospital at Gangdong, Seoul
Registry updated 2026-01-12
NCT07163260
Defeat Rare Disease in Asia and Pacific (APAC) DRDA - Haemophilia
Research · Novo Nordisk A/S
Seoul
Registry updated 2025-10-24

All Haemophilia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error